# VACCINE AND TREATMENT EVALUATION UNITS: PHASE II VACCINE TRIAL FOR INFLUENZA

> **NIH NIH N01** · EMORY UNIVERSITY · 2022 · $5,000

## Abstract

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations.

## Key facts

- **NIH application ID:** 10710347
- **Project number:** 272201300018I-P00004-27200019-1
- **Recipient organization:** EMORY UNIVERSITY
- **Principal Investigator:** NADINE ROUPHAEL
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $5,000
- **Award type:** —
- **Project period:** 2017-07-28 → 2024-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10710347

## Citation

> US National Institutes of Health, RePORTER application 10710347, VACCINE AND TREATMENT EVALUATION UNITS: PHASE II VACCINE TRIAL FOR INFLUENZA (272201300018I-P00004-27200019-1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10710347. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*